Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     Pharmaceuticals     Drug formulations     ATC    

Global Cardiovascular System Market Research Report

PRODUCT TITLE PUBLISHED
Non-selective calcium channel blockers Non-selective calcium channel blockers
Non-selective calcium channel blockers and its peer markets - Selective calcium channel blockers with mainly vascular...
Upcoming
Calcium channel blockers and diuretics Calcium channel blockers and diuretics
Calcium channel blockers and diuretics and its peer markets - Selective calcium channel blockers with direct cardiac...
Upcoming
Ace inhibitors, plain Ace inhibitors, plain
Ace inhibitors, plain and its peer markets - Immunoassay, Ace...
Upcoming
Ace inhibitors, combinations Ace inhibitors, combinations
Ace inhibitors, combinations and its peer markets - Ace inhibitors, plain,
Upcoming
Angiotensin II antagonists, plain Angiotensin II antagonists, plain
Angiotensin II antagonists, plain and its peer markets - Ace inhibitors, plain,
Upcoming
Angiotensin II antagonists, combinations Angiotensin II antagonists, combinations
Angiotensin II antagonists, combinations and its peer markets - Healthcare IT outsourcing,
Upcoming
Lipid modifying agents, plain Lipid modifying agents, plain
Lipid modifying agents, plain and its peer markets - Wireless Health,
Upcoming
Lipid modifying agents, combinations Lipid modifying agents, combinations
Lipid modifying agents, combinations and its peer markets - Chromatography,
Upcoming
Peripheral vasodilator enzymes Peripheral vasodilator enzymes
Peripheral vasodilator enzymes and its peer markets - E-Clinical Trial Solutions,
Upcoming
Agents for treatment of hemorrhoids and anal fissures for topical use Agents for treatment of hemorrhoids and anal fissures for topical use
Agents for treatment of hemorrhoids and anal fissures for topical use and its peer markets - Immunoassay,
Upcoming
Digitalis glycosides Digitalis glycosides
Digitalis glycosides and its peer markets - Clinical Trial Management Systems (CTMS),
Upcoming
Scilla glycosides Scilla glycosides
Scilla glycosides and its peer markets - Next Generation Sequencing (NGS),
Upcoming
Strophantus glycosides Strophantus glycosides
Strophantus glycosides and its peer markets - E-Clinical Trial Solutions,
Upcoming
Antiarrhythmics, class Ia Antiarrhythmics, class Ia
Antiarrhythmics, class Ia and its peer markets - Antiarrhythmics, class III,
Upcoming
Antiarrhythmics, class Ib Antiarrhythmics, class Ib
Antiarrhythmics, class Ib and its peer markets - Other class I antiarrhythmics,
Upcoming
Antiarrhythmics, class Ic Antiarrhythmics, class Ic
Antiarrhythmics, class Ic and its peer markets - Antiarrhythmics, class Ib,
Upcoming
Antiarrhythmics, class III Antiarrhythmics, class III
Antiarrhythmics, class III and its peer markets - Antiarrhythmics, class Ib,
Upcoming
Adrenergic and dopaminergic agents Adrenergic and dopaminergic agents
Adrenergic and dopaminergic agents and its peer markets - Wireless Health,
Upcoming
Phosphodiesterase inhibitors Phosphodiesterase inhibitors
Phosphodiesterase inhibitors and its peer markets - Clinical Trial Management Systems (CTMS),
Upcoming
Organic nitrates Organic nitrates
Organic nitrates and its peer markets - Clinical Trial Management Systems (CTMS),
Upcoming
117 reports | Show
Connect With Us
US/CAN : +1-888-502-0539